ReportsandReports: Biosimilars Series - Forecast Analysis Market Research Report

DALLAS, Texas, February 2 - ReportsandReports announce to have Biosimilars Series: Forecast Analysis
(www.reportsandreports.com/market-reports/biosimilars-series-Forecast-
Analysis/) Market Research Report in its store

The high cost and utilization of biologic drugs, coupled to the growing
need to curb pharmaceutical expenditure, provides considerable momentum to
the emerging biosimilars market. With a biosimilar approval pathway in place
in Europe and Japan, and imminently in the US, Datamonitor expects payer
pressure to drive biosimilar uptake, particularly in Germany, the US, and the
UK.

    Scope

    - Molecule-specific forecasts for biosimilar epoetin alpha, filgrastim,
      interferon beta, interferon alpha, human growth hormone, and
      insulin-glargine.

    - Molecule-specific forecasts for France, Germany, Italy, Spain, the US,
      and Japan through 2019.

    - An overview of the emerging biosimilars market, including a regulatory
      update.

    - An outline of the key issues which will impact on biosimilars uptake
      going forward.

Highlights

As the first to introduce guidelines for biosimilar drug approval, Europe
has emerged as the testing ground for biosimilar drugs, with biosimilars for
three biologics having entered the market to date human growth hormone,
epoetin alpha, and filgrastim.

The size of the US market, combined with the voracious generic erosion
that characterize it, make it an attractive prospect for would-be biosimilars
makers, and as such, it represents the real prize, contingent on the creation
of a biosimilars approval pathway.

Although guidance for biosimilar approval was issued in Japan in 2009,
this market is unlikely to experience significant biosimilar incursion
through the forecast period, contributing at most 1% to total seven major
market volume sales in 2019.

Reasons to Purchase

    - Learn how biosimilar uptake for six biologic drugs is anticipated to
      change through 2019, in France, Germany, Italy, Spain, the UK, the US,
      and Japan.

    - Understand how the seven major markets compare in terms of speed and
      extent of biosimilars uptake.

    - Identify the key molecule and market specific drivers and resistors to
      biosimilar uptake.

Related Reports

HVAC in the U.S., 2nd Edition - Green and Global (
www.reportsandreports.com/market-reports/hvac-in-the-us-2nd-edition-%E
2%80%94-green-and-global/)

Global Biomaterial Market (2009-2014) (
www.reportsandreports.com/market-reports/global-biomaterial-market-200
9-2014/)

World Market for Biosimilars and the Potential for US Followon Biologics
(www.reportsandreports.com/market-reports/world-market-for-biosimilars
-and-the-potential-for-us-followon-bi/)

(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if one exists.)

    Contact:

    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    www.reportsandreports.com/

Contact: Ms. Sunita, 7557 Rambler road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004